Showing 20 of 22 recruiting trials for “granulomatous-mastitis”
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
👨⚕️ Paul Szabolcs, MD, UPMC Children's Hospital of Pittsburgh📍 1 site📅 Started Mar 2026View details ↗
Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis
👨⚕️ Xavier PUECHAL, PhD, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris - Service de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques "📍 1 site📅 Started Dec 2025View details ↗
Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
👨⚕️ STEFANO DEL GIACCO, MD, AZIENDA OSPEDALIERA UNIVERSITARIA CAGLIARI📍 1 site📅 Started Oct 2025View details ↗
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
👨⚕️ Elizabeth M Kang, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Sep 2025View details ↗
Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
RecruitingNCT06605378 ↗
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)
👨⚕️ Elizabeth M Kang, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jun 2024View details ↗
Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis
Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
👨⚕️ Suk S De Ravin, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06298448 ↗
eGPA and Local Inflammation Within the Ear, Nose and Throat Area
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）
Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications
👨⚕️ Christa S Zerbe, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Aug 2022View details ↗
Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis
👨⚕️ Suchitra K Hourigan, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Aug 2022View details ↗
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
👨⚕️ Suk S De Ravin, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jul 2022View details ↗
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
👨⚕️ Elizabeth M Kang, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jul 2022View details ↗
Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD
RecruitingNCT01241305 ↗
One-Time DNA Study for Vasculitis
RecruitingNCT00315380 ↗
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →